The Company showcasing a turnaround for the quarter has reported net profit at Rs 150.37 crore as compared to net loss of Rs 7.7 lakh for the quarter ended June 30, 2010 has reported results for the quarter ended June 30, 2011. Its total income has surged by 8.14% at Rs 1326.76 crore for the quarter under review from Rs 1226.86 crore for the corresponding quarter of the previous year.
On Consolidated basis, the Group ‘s profit after tax and minority interest has declined by 21.32% at Rs 243.23 crore for the quarter from Rs 325.71 crore for the corresponding quarter of the previous Fiscal. Its total Income has decreased by 4.31% at Rs 2172.26 crore for Q1FY12 from Rs 2270.07 crore for the Q1FY11.
Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has its R & D centre that helps company to have long term competive advantage.It caters treatment to segment of diseases that includes Cardiovasculars, Central Nervous System, Respiratory, Dermatology, Orthopedics, Nutritionals and Urology.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1787.10 |
| Dr. Reddys Lab | 1271.75 |
| Cipla | 1376.25 |
| Zydus Lifesciences | 1097.90 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: